Mobius® Breez Microbioreactor: The Smallest, Automated, High-Throughput Bioreactor Yet

The Mobius^® Breez Microbioreactor is a 2 mL automated, single-use perfusion cell culture platform designed to support gentle, adaptable, and reproducible cell processes. The system is capable of accelerating a range of applications such as cell line development, media screening and optimization, and early process development. The Mobius^® Breez Microbioreactor allows you to increase efficiency and reduce development timelines and costs over traditional technologies that require more material consumption.

Learn more here

Email*

Choose a password*

I have read and understand the Privacy Notice *

Stay up to date with our other newsletters and sponsors information, tailored specifically to the fields you are interested in

I want to stay up to date with the "Small Molecule" field I want to stay up to date with the Cell and Gene field I want to stay up to date with the Bioprocessing field

When you click “Subscribe” we will email you a link, which you must click to verify the email address above and activate your subscription. If you do not receive this email, please contact us at [email protected].
If you wish to unsubscribe, you can update your preferences at any point.

Contact Info:

Address: MilliporeSigma, 400 Summit Drive, Burlington, MA 01803

Main Number: (866) 645-5476

Fax Number: (800) 645-5439

Email: [email protected]

The Life Science business of Merck KGaA, Darmstadt, Germany, which operates as MilliporeSigma in the U.S. and Canada, has 20,000 employees and 60 manufacturing sites worldwide, with a portfolio of more than 300,000 products enabling scientific discovery. Udit Batra is the global chief executive officer of MilliporeSigma.

Beyond "Disease X": Strategic R&D in an Era of Emerging Threats

10/30/2024 | Sponsored by Biosynth